The Bluegrass State is joining the green rush—but in true Kentucky fashion, they're doing it their own way. Join Emily Paxhia (Poseidon) and Cy Scott (Headset) as they break down Kentucky's cautious entry into medical cannabis, and what it means for operators, investors, and entrepreneurs.

In this episode, our hosts dive deep into:

Kentucky's unique approach to medical cannabis (spoiler: leave your rolling papers at home)
Why most licenses went to out-of-state operators, and what that means for the market
How Kentucky stacks up against Missouri, Mississippi, and Florida
Where the real opportunities lie for entrepreneurs who missed the licensing lottery
Market projections and investment potential that might surprise you

Whether you're an MSO executive, an ancillary business owner, or an investor eyeing the next frontier market, this episode offers critical insights into one of the newest medical markets in the United States. Plus, Emily and Cy share their signature market analysis on whether Kentucky could follow Florida's highly profitable path or face Mississippi's growing pains.

Pour yourself a bourbon (or your favorite alternative), and join us for an hour of market intelligence, strategic insights, and maybe even a table flip or two. 🥃

Headset

E167 - Bluegrass Bud: Kentucky Medical Cannabis Arrives 38:33 Share

High Rise: Cannabis MSOs, Products & Market Analysis

Shownotes Transcript

E167 - Bluegrass Bud: Kentucky Medical Cannabis Arrives